Semaglutide, the Active Ingredient in Ozempic and Wegovy, Is Transforming Metabolic Healthcare.

Description

Sales manager: Lucky
WhatsApp: +852 4641 5605
Email: OrlaneSissoko992@gmail.com

• De scription:Semaglutide, is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.

• Basic information Semaglutide, also known as semaglutide in Chinese, is a new type of therapeutic drug belonging to the class of GLP-1 receptor agonists. Its chemical structure is derived from the modification of naturally occurring glucagon-like peptide-1 (GLP-1), which gives it unique pharmacological properties and is significantly different from the mechanism of action of traditional hypoglycemic drugs.

  Indications

  1. Treatment of type 2 diabetes: It is used for blood sugar control in adult patients with type 2 diabetes on the basis of diet control and exercise. Especially for those patients whose blood sugar is still poorly controlled after treatment with metformin and/or sulfonylurea drugs. Semaglutide can stimulate insulin secretion, and this stimulation is glucose concentration-dependent, that is, it enhances insulin secretion when blood sugar rises, effectively reduces high blood sugar levels, and reduces the risk of hypoglycemia when blood sugar is normal; at the same time, it inhibits glucagon secretion, reduces liver glucose output, and can also delay gastric emptying, prolong nutrient absorption time, and further stabilize blood sugar levels.

  2. Reduction of cardiovascular disease risk: It is suitable for adult patients with type 2 diabetes and cardiovascular disease, and can reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke). It may protect the cardiovascular system by improving endothelial function, reducing inflammatory response and directly protecting the heart.

  3. Weight management: It can be used to assist weight management for adults with BMI ≥ 30kg/m² (obesity) or BMI ≥ 27kg/m² (overweight) and at least one weight-related complication (such as hypertension, dyslipidemia, cardiovascular disease, sleep apnea, etc.). Semaglutide acts on the appetite regulation center of the hypothalamus, increases satiety signals, and affects the reward circuit of the limbic system, reducing the desire for high-fat and high-sugar foods, thereby reducing food intake and achieving weight loss.

Preparation: Sommarutide was prepared by solid-liquid phase synthesis method. Straight chain peptide Aib8, Arg34GLP-1(7-37) and fatty side chain acylating agent were prepared by solid phase synthesis method. Straight chain peptide Lys26 was modified by synthetic fatty chain acylating agent under alkaline conditions to obtain sommarutide. The biological activity of self-made samples was determined by time-resolved fluorescence resonance energy transfer immunoassay.

The storage conditions of Semaglutide are:
Before first use, store in the refrigerator at a temperature of 2°C-8°C, dry, protected from light, and sealed.
Do not freeze and do not use after freezing.
Keep out of reach of children.
In actual operation, the storage conditions recommended by the product instructions or doctors should be followed.

5mg/vial,10vials/box;

10mg/vial,10vials/box;

15mg/vial,10vials/box;

20mg/vial,10vials/box;

30mg/vial,10vials/box;

（Take T30 as an example）

Customers can specify express delivery, such as: UPS/DHL, etc. (Default express delivery: our cooperative logistics company)

Beijing Qiangpi Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development and production of peptide products. Established in recent years, the company is committed to applying advanced biotechnology to the health industry to meet the market demand for high-quality and efficient peptide products.
As a leading peptide product manufacturer, the company’s main products cover, but are not limited to, the fields of pharmaceutical grade, food grade and cosmetic grade, and are widely used in health care, disease prevention, beauty and skin care, etc.
At the same time, the company has established a complete quality management system and after-sales service system to provide customers with comprehensive and one-stop service support.
The corporate philosophy of “Quality creates the future” always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills social responsibilities, committed to promoting the development and progress of the health industry.
In the future, Beijing Qiangpi Biotechnology Co., Ltd. will continue to delve into the field of peptide product research and development, constantly explore and achieve breakthroughs, and strive to become a leading enterprise in the global peptide industry, making greater contributions to human health.